Among patients with abdominal obesity, there was increased use of anticoagulation (P < .001), angiotensin‐converting enzyme inhibitor or angiotensin‐receptor blocker (P < .001), beta‐blockers (P < .001), diuretics (P < .001), aldosterone antagonist (P < .001) and statins (P < .001). The gene discussed is ACE; the disease is Abdominal obesity.